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Abstract
Introduction Permeability changes in the blood–brain barrier (BBB) and their possible contribution to
brain edema formation have a crucial role in the pathophysiology of septic encephalopathy. Magnesium
sulfate has been shown to have a protective effect on BBB integrity in multiple experimental models. In
this study we determine whether magnesium sulfate administration could have any protective effects
on BBB derangement in a rat model of sepsis.
Methods This randomized controlled experimental study was performed on adult male Sprague–
Dawley rats. Intraperitoneal sepsis was induced by using the infected fibrin–thrombin clot model. To
examine the effect of magnesium in septic and sham-operated rats, a dose of 750 µmol/kg magnesium
sulfate was given intramuscularly immediately after surgery. Control groups for both infected and sham-
operated rats were injected with equal volume of saline. Those rats surviving for 24 hours were
anesthetized and decapitated for the investigation of brain tissue specific gravity and BBB integrity by
the spectrophotometric assay of Evans blue dye extravasations. Another set of experiments was
performed for hemodynamic measurements and plasma magnesium level analysis. Rats were allocated
into four parallel groups undergoing identical procedures.
Results Sepsis significantly increased BBB permeability to Evans blue. The dye content of each
hemisphere was significantly lower in the magnesium-treated septic rats (left hemisphere, 0.00218 ±
0.0005; right hemisphere, 0.00199 ± 0.0007 [all results are means ± standard deviation]) than in
control septic animals (left hemisphere, 0.00466 ± 0.0002; right hemisphere, 0.00641 ± 0.0003). In
septic animals treated with magnesium sulfate, specific gravity was higher (left hemisphere, 1.0438 ±
0.0007; right hemisphere, 1.0439 ± 0.0004) than in the untreated septic animals (left hemisphere,
1.0429 ± 0.0009; right hemisphere, 1.0424 ± 0.0012), indicating less edema formation with the
administration of magnesium. A significant decrease in plasma magnesium levels was observed 24
hours after the induction of sepsis. The dose of magnesium that we used maintained the baseline
plasma magnesium levels in magnesium-treated septic rats.
Conclusions Magnesium administration attenuated the increased BBB permeability defect and
caused a reduction in brain edema formation in our rat model of intraperitoneal sepsis.
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Introduction
Patients with severe sepsis often manifest symptoms of
encephalopathy. Acute alterations in mental status, which
occur fairly frequently in septic patients, have been shown to
be associated with poor prognosis [1]. However, not much is
known about the exact mechanism of brain injury in sepsis.
Studies have suggested that septic encephalopathy might
involve a disturbance of plasma and brain neutral amino acid
transport across the blood–brain barrier (BBB), similar to
those seen in porto-systemic encephalopathy. This process
has been related to the breakdown of the BBB because
patients with septic encephalopathy have high protein levels in
the cerebrospinal fluid [2]. Recently, derangements in the
BBB causing perivascular edema have been demonstrated in
sepsis-induced pigs [3].
Protective effects of magnesium sulfate (MgSO4) against
BBB breakdown after severe insulin-induced hypoglycemia
have been reported in animals [4]. Similar effects of magne-
sium on BBB were also evident in a diffuse traumatic brain
injury model in rats [5-7].
In summary, MgSO4 was shown to have a protective effect on
BBB integrity in multiple experimental models. We hypothe-
sized that MgSO4 will also protect against BBB derangements
observed in sepsis and tested the hypothesis in a rat model of
sepsis induced by an intraperitoneally inserted infected fibrin–
thrombin clot.
Methods
One hundred and twenty-six male Sprague–Dawley rats
weighing 320–440 g were used in this study. Rats were pur-
chased from the Institute for Experimental Research and Appli-
cation (Istanbul Medical Faculty), and were cared for before
and during all stages of the experimental protocol in compli-
ance with the applicable institutional guidelines and regula-
tions of the Institute for Experimental Medicine Research and
Application.
Rats were prepared for surgery under anesthesia with intra-
muscular 100 µg/g ketamine (Parke-Davis, Morris Plains, NJ,
USA) and 20 µg/g xylazine hydrochloride Rompun 2% (Bayer,
Munich, Germany) and allowed to breathe spontaneously. The
loss of corneal reflex and no movement in response to a painful
stimulus confirmed maintenance of adequate anesthesia for
the experimental procedure. The rats were subsequently rand-
omized into one of four groups: sham control (C), sham control
MgSO4-treated (C-Mg), septic (S) and septic with MgSO4 (S-
Mg).
Intraperitoneal sepsis was induced with the infected fibrin–
thrombin clot model described by Mathiak and colleagues [8].
Fibrin–thrombin clots were formed by adding 2 ml of 1% ster-
ile fibrinogen solution, 1 ml of a bacterial suspension (1.8 ×
109 colony-forming units/ml [infected] or vehicle [sterile 0.9%
NaCl]) and 160 µl (100 units/ml) of sterile human thrombin to
a 5 ml syringe. The resulting clot was then incubated at room
temperature for 30 min before implantation into the abdominal
cavity. The Escherichia coli strain was isolated from an intra-
abdominal collection from a patient with secondary peritonitis.
The bacteria were inoculated into a brain heart infusion broth
(DIFCO Laboratories, Detroit, MI, USA) and incubated over-
night at 35°C. The count of E. coli was adjusted to 1.8 × 109
colony-forming units/ml with McFarland standard 6. After mak-
ing a 0.5 cm midline abdominal incision, the peritoneum was
opened and the prepared clot was injected into the peritoneal
cavity directly from the syringe. Sham-operated rats had a ster-
ile clot injected into their peritoneal cavity. To examine the
effect of magnesium in septic and sham-operated rats, a dose
of 750 µmol/kg MgSO4 was given intramuscularly immediately
after surgery. Control groups for both infected and sham-oper-
ated rats were injected with an equal volume of saline.
After surgery, the animals were given 50 µl/g per hour of saline
subcutaneously and were allowed to wake up while breathing
spontaneously. They were returned to their cages and were
allowed free access to water. Those rats surviving for 24 hours
after the surgery were anesthetized and decapitated for the
investigation of brain tissue specific gravity (SG) and BBB
integrity.
We used the method described by Mikawa and colleagues [9]
to determine BBB integrity by Evans blue (EB) dye. EB dye (4
ml/kg, 2%) was administered intravenously and allowed to cir-
culate for 60 min. The animals were then perfused with saline
through the left ventricle at a pressure of 110 mmHg until
colorless fluid was obtained from the right atrium. Afterwards,
the brains were removed and dissected. Each hemisphere
was weighed and the samples were then homogenized in 3.5
ml phosphate-buffered saline and vortex-mixed for 2 min after
the addition of 2.5 ml of 60% trichloroacetic acid to precipitate
protein. The samples were then cooled for 30 min and centri-
fuged for 30 min at 1000 r.p.m. The absorbance of the super-
natants for EB dye was measured at 610 nm with a
spectrophotometer. EB dye content is expressed as µg/mg of
brain tissue against a standard curve.
The method defined by Marmarou and colleagues was used
for the determination of SG [10]. We obtained 1 mm3 samples
taken from the right and left hemispheres of each animal. Sam-
ples were placed into linear density gradient columns of kero-
sene and bromobenzene. A calibration curve was determined
for each column by using anhydrous K2SO4  solutions of
known SG (1.045, 1.040, 1.035 and 1.025). Brain tissue SG
values were subsequently determined with this calibration
curve.
Another set of experiments were performed for hemodynamic
measurements and plasma magnesium level analysis. These
rats were allocated into four parallel experimental groups withAvailable online http://ccforum.com/content/9/1/R18
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identical procedures. Right femoral artery catheterization was
performed under general anesthesia for blood pressure moni-
toring and blood sampling. Blood samples (0.5 ml) were taken
for the determination of plasma magnesium levels at baseline
(T0) and 24 hours (T24) after the induction of sepsis, and an
equal volume of saline was given. Mean arterial pressure was
recorded at baseline and 2, 3, 4, 8, 12 and 24 hours after the
surgical procedure. Four of 12 rats in group S and 3 of 11 rats
in group S-mg died within 24 hours of the induction of sepsis.
Data for these rats were excluded from the study. We contin-
ued to enter rats with a balanced randomization sequence until
we had eight surviving rats for each group.
Statistical analysis
The results are expressed as means ± standard deviation. EB
dye content, brain tissue SG, serum magnesium levels, mean
arterial pressures and heart rates were compared among four
groups with a Kruskal–Wallis analysis of variance followed by
Dunn's multiple comparisons test. A Mann–Whitney U-test
and a Friedman nonparametric repeated-measures test were
used for within-group comparisons. Paired serum magnesium
levels were compared within each group by using a Wilcoxon
signed rank test. Mortality rate was compared between septic
groups receiving and not receiving magnesium with a χ2 test.
A probability (P) of less than 0.05 was considered significant.
Results
Thirteen of 29 rats in group S and 10 of 26 rats in group S-Mg
died within 24 hours after the induction of sepsis, whereas all
of the rats in groups C and C-Mg survived. The mortality rate
was not statistically different between septic rats receiving
and not receiving magnesium (in the experimental groups, χ2
= 0.229, P = 0.632; in the monitoring groups, χ2 = 0.100, P
= 0.752). Both groups of septic rats appeared ill as demon-
strated by exudates around nose and eyes, tachypnea and
decreased spontaneous movement. Sham-operated rats
seemed grossly normal and were active within their cages.
Changes in mean arterial pressure are summarized in Figure 1.
A significant decrease was observed 2 hours after the induc-
tion of sepsis in groups S and S-Mg. No further changes in
blood pressures were observed with the administration of
magnesium in the control and sepsis groups.
Plasma magnesium levels were comparable between groups
at baseline (Table 1). A significant decrease in plasma magne-
sium levels was observed 24 hours after the induction of sep-
sis. An intramuscular dose of 750 µmol/kg MgSO4 maintained
the baseline plasma magnesium levels in magnesium-treated
septic rats.
Quantitative estimation of the EB dye revealed that sepsis sig-
nificantly increased BBB permeability as measured by EB
extravasations into brain tissue. In the S-Mg group, BBB per-
meability was significantly decreased in comparison with the S
group (Table 2).
The SG of both hemispheres taken from sepsis-induced rats
were significantly less than the sham-operated rats, indicating
the formation of brain edema after the induction of sepsis
(Table 3). Brain tissue SG measurements in the magnesium-
treated septic rats were significantly higher than in the
untreated sepsis group. Within-group comparisons indicated
no difference between the right and left hemispheres.
Discussion
The results of the present study demonstrate that treatment
with magnesium immediately after experimental sepsis
attenuated BBB permeability and the extent of brain edema
formation.
Alterations of BBB permeability with subsequent brain edema
formation are common features of septic encephalopathy.
Several hypotheses for the pathogenesis of septic encepha-
lopathy have been discussed in the literature: metabolic
derangement, direct bacterial invasion of the central nervous
system, the effect of endotoxin on the brain, or altered cerebral
macrocirculation and microcirculation [11-16]. Recent evi-
dence implicates the changes in the BBB permeability that
favor brain edema formation in the pathophysiology of septic
encephalopathy [3,17]. In our model the BBB permeability
defect induced by sepsis, as demonstrated by the EB dye
extravasation technique, is consistent with previous reports
demonstrating a loss of BBB integrity as a result of a septic
Figure 1
Hemodynamic data Hemodynamic data. Groups: sham control (C, n = 8), sham control 
MgSO4-treated (C-Mg, n = 8), septic (S, n = 8) and septic MgSO4-
treated (S-Mg, n = 8). Mean arterial pressures compared among four 
groups using a Kruskal–Wallis analysis of variance followed by Dunn's 
multiple comparisons test. aSeptic versus sham control, P < 0.05. 
bSeptic versus sham control MgSO4-treated, P < 0.05. cAt 2 hours 
after the induction of sepsis versus baseline value (in the septic group), 
P < 0.01. dSeptic MgSO4-treated versus sham control MgSO4-treated, 
P < 0.01. eAt 2 hours after the induction of sepsis versus baseline value 
(in the septic MgSO4-treated group), P < 0.05. A Friedman nonpara-
metric repeated-measures test was used for within-group comparisons.Critical Care    February 2005  Vol 9 No 1    Esen et al.
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challenge; however, the change in the SG representing brain
tissue edema formation was relatively minor. Although the
small change in SG that we obtained in the sepsis group
reached statistical significance, indicating some amount of
edema formation with the induction of sepsis, it is not possible
to relate the edema formation to the disturbed integrity of the
BBB.
Our results are consistent with previous reports on the integ-
rity of the BBB and the role of a permeability defect in the for-
mation of cerebral edema using other models of cerebral
damage [18-20]. In our previous experimental study we evalu-
ated the effects of magnesium on brain edema formation and
BBB breakdown after closed-head trauma in rats [5]. Our
results of BBB breakdown by the measurement of EB dye
extravasation were comparable with those that we obtained in
our sepsis model; however, the changes in SG were higher in
the traumatic brain injury model than in our sepsis model. This
might be explained by the different mechanisms causing BBB
breakdown and edema formation in trauma and sepsis. The
discrepancy between brain edema and BBB permeability
defect in sepsis might also indicate a low grade of permeability
defect due to the complex cascade of sepsis, which is not
enough to create edema as such in trauma. Another possible
explanation might be that the quantitative determination of
BBB permeability defect by EB dye extravasation is more sen-
sitive than the SG method for determining brain edema.
Other methods have been used to determine BBB damage in
septic encephalopathy. In rodents with sepsis, colloidal iron
dioxide [21], 14C-labelled amino acids [22] and 125I-labelled
albumin [23] have been shown to pass from the circulation
into the brain parenchyma in a similar manner to that seen in
portosystemic encephalopathy. However, there is no evidence
in the literature to suggest that this damage is related to
edema formation in sepsis. Most recently, morphologic
Table 1
Plasma magnesium concentrations
Measurement Group (n)T 0 T 2 4 P
Plasma Mg (mM) C (8) 1.11 ± 0.05 1.10 ± 0.05 NS
S (8) 1.09 ± 0.05 0.89 ± 0.06a,b 0.0078
C-Mg (8) 1.10 ± 0.06 1.29 ± 0.06 0.0078
S-Mg (8) 1.13 ± 0.03 1.01 ± 0.08c 0.0156
KW 2.708 26.863
d.f. 3 3
P >0.05 <0.0001
Abbreviations: d.f., degrees of freedom; KW, Kruskal–Wallis test statistic; NS, not significant; P, approximate χ2 P value; T0, basal measurement; 
T24, measurement at 24 hours. Groups: sham control (C), sham control MgSO4-treated (C-Mg), septic (S) and septic MgSO4-treated (S-Mg). 
Data are expressed as means ± standard deviation.
Dunn's multiple comparisons test: aseptic versus sham control, P < 0.05; bseptic versus sham control MgSO4-treated, P < 0.001; cseptic 
MgSO4-treated versus sham control MgSO4-treated, P < 0.01. Paired serum magnesium levels were compared within groups using a Wilcoxon 
signed rank test. Two-tailed P values are shown in the last column.
Table 2
Assessment of blood–brain barrier permeability by Evans blue dye content in brain tissue
Measurement Group (n) Left hemisphere Right hemisphere P
EB dye (µg/g) C (8) 0.00160 ± 0.0003 0.00145 ± 0.0003 0.33
S (8) 0.00466 ± 0.0002a,b 0.00641 ± 0.0003c,d 0.13
C-Mg (8) 0.00135 ± 0.0002 0.00145 ± 0.0003 0.44
S-Mg (8) 0.00218 ± 0.0005 0.00199 ± 0.0007 0.57
KW 19.720 23.039
d.f. 3 3
P < 0.001 < 0.0001
Abbreviations: d.f., degrees of freedom; EB, Evans blue; KW, Kruskal–Wallis test statistic; P, approximate χ2 P value. Groups: sham control (C), 
sham control MgSO4-treated (C-Mg), septic (S) and septic MgSO4-treated (S-Mg). Data are expressed as means ± standard deviation.
Dunn's multiple comparisons test: aseptic versus sham control, P < 0.01; bseptic versus sham control MgSO4-treated, P < 0.001; cseptic versus 
sham control, P < 0.001; dseptic versus sham control MgSO4-treated, P < 0.001. A Mann–Whitney test was used for within-group comparisons. 
Two-tailed P values are shown in the last column.Available online http://ccforum.com/content/9/1/R18
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changes have been showed in the frontal cortex of a pig model
of sepsis [3]. Fecal peritonitis resulted in severe perimicroves-
sel edema that was associated with swelling and rupture of
astrocyte endfeet. Although this was suggested as evidence
for the breakdown of the BBB, the ultrastructure of intercellu-
lar tight junctions seemed morphologically intact in pigs with
sepsis. The authors have suggested that some other mecha-
nism might be involved in the formation of edema. It is not
known whether edema formation is related to BBB breakdown
or other factors in sepsis. The exact mechanism and the rela-
tion between BBB breakdown and edema formation in sepsis-
induced brain injury need to be further evaluated by more sen-
sitive methods.
A major finding of the present study is that magnesium admin-
istration attenuates the increase in BBB permeability and
edema formation. The exact mechanism of magnesium's ben-
eficial effect on the integrity of the BBB is unclear. However,
magnesium can affect many aspects of the mediator cascade
that can cause a permeability defect in the BBB. Alternatively,
magnesium can act directly on the BBB. Magnesium's cyto-
protective effect to reduce the profound breakdown of the
BBB was first demonstrated in a rat model of severe insulin-
induced hypoglycemia [4]. In this study it was speculated that
magnesium might exert this effect through suppression of the
endothelial cells. It was suggested that even before magne-
sium reaches the brain site it interacts with the endothelial
cells forming the BBB and inhibits their activation [4,24,25].
To our knowledge, the present data are the first to show the
positive effects of magnesium on sepsis-induced BBB perme-
ability changes. Although this might have clinical significance,
a contrary suggestion could be that increasing the integrity of
the BBB might also have negative effects in terms of antibiotic
emergence when the clinical situation is complicated with
encephalitis or meningitis. In our model of intra-abdominal sep-
sis, the cultures of brain specimens taken after the experiment
were all sterile (data not shown).
One of the major pitfalls in the interpretation of the data was
the difficulty of establishing a dose response for magnesium.
In our present study the dose and the timing of magnesium
administration were chosen with reference to our previous
experiments on traumatic brain injury [5]. This dose of
magnesium was determined as an optimum dose showing the
best neurologic outcome in a traumatic brain injury model [26].
Plasma magnesium levels decreased significantly with the
induction of sepsis and returned to nearly control levels with
the dose of magnesium that we administered. However, it is
known that the plasma magnesium level does not represent
tissue magnesium content, and the lack of correlation between
plasma magnesium and total body magnesium content in
healthy subjects has already been reported [27]. More
recently, it was demonstrated that free magnesium levels in
brain tissue is a sensitive method that reflects magnesium
homeostasis in a traumatic brain injury model [28]. Although
we do not know to what extent the plasma magnesium levels
represent brain tissue levels in the present study, our data
show that significant beneficial effects are achievable with the
dose administered. However, future studies will be needed to
establish a dose response by measuring free magnesium lev-
els in brain tissue for the effects of magnesium therapy in sep-
sis-induced brain injury.
Conclusion
This investigation shows that sepsis increases BBB permea-
bility and leads to the formation of brain edema in septic rats.
Magnesium administration attenuated the increased BBB per-
meability and caused a reduction in brain edema formation in
our rat model of intraperitoneal sepsis. The precise mecha-
Table 3
Assessment of edema by specific gravity of brain tissue
Measurement Group (n) Left hemisphere Right hemisphere P
SG C (8) 1.0444 ± 0.0001 1.0443 ± 0.0002 0.24
S (8) 1.0429 ± 0.0009a,b 1.0424 ± 0.0012c,d 0.44
C-Mg (8) 1.0444 ± 0.0002 1.0444 ± 0.0001 0.44
S-Mg (8) 1.0438 ± 0.0007 1.0439 ± 0.0004e 0.24
KW 18.831 24.724
d.f. 3 3
P < 0.001 <0.0001
Abbreviations: d.f., degrees of freedom; KW, Kruskal–Wallis test statistic; P, approximate χ2 P value; SG, specific gravity. Groups: sham control 
(C), sham control MgSO4-treated (C-Mg), septic (S) and septic MgSO4-treated (S-Mg). Data are expressed as means ± standard deviation.
Dunn's multiple comparisons test: aseptic versus sham control, P < 0.001; bseptic versus sham control MgSO4-treated, P < 0.01; cseptic versus 
sham control, P < 0.01; dseptic versus sham control MgSO4-treated, P < 0.001; eseptic MgSO4-treated versus sham control MgSO4-treated, P 
< 0.05. A Mann–Whitney test was used for within-group comparisons. Two-tailed P values are shown in the last column.Critical Care    February 2005  Vol 9 No 1    Esen et al.
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nisms and the pharmacodynamics of magnesium administra-
tion in sepsis-induced brain injury need further investigation.
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Key messages
•  Sepsis causes BBB permeability defect.
•  Magnesium attenuates the increased BBB permeabil-
ity associated with sepsis.